tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
Advertisement

Urogen Pharma (URGN) Technical Analysis

Compare
619 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is 1.32, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 18.45, while Urogen Pharma’s (URGN) share price is $19.71, making it a Buy.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 15.78, while Urogen Pharma’s (URGN) share price is $19.71, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Aug 17, 2025, 04:11 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.00
19.28
19.68
19.97
20.37
20.65
21.05
Fibonacci
19.28
19.54
19.70
19.97
20.23
20.39
20.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Aug 17, 2025, 04:11 PM
Period
Simple
Exponential
MA5
19.47Buy
19.59Buy
MA10
19.43Buy
19.31Buy
MA20
18.89Buy
18.45Buy
MA50
15.14Buy
15.78Buy
MA100
12.12Buy
13.69Buy
MA200
11.63Buy
12.91Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 19.31, while Urogen Pharma’s (URGN) share price is $19.71, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 13.69, while Urogen Pharma’s (URGN) share price is $19.71, making it a Buy.
Urogen Pharma’s (URGN) stock price is $19.71 and Urogen Pharma’s (URGN) 50-day simple moving average is 15.14, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $19.71 and Urogen Pharma’s (URGN) 100-day simple moving average is 12.12, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $19.71 and Urogen Pharma’s (URGN) 200-day simple moving average is 11.63, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Aug 17, 2025, 04:11 PM
Name
Value
Implied Action
RSI (14)
62.56
Neutral
STOCH (9,6)
73.43
Neutral
STOCHRSI (14)
73.43
Neutral
MACD (12,26)
1.32
Buy
ADX (14)
41.20
Neutral
Williams %R
-33.08
Buy
CCI (14)
84.54
Neutral
ATR (14)
1.21
-
Ultimate Oscillator
59.45
Neutral
ROC
4.29
Buy
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 62.56, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 41.20, creating a Neutral signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is 84.54, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is 4.29, creating a Buy signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Strong Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 62.56, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is 1.32, which suggests URGN is a Buy.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 19.47, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 18.89, which suggests URGN is a Buy.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 15.14, which suggests URGN is a Buy.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 11.63, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -33.08, which suggests URGN is a Buy.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is 84.54, which suggests URGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis